This regular update (no. 76 | 9 February 2022 ) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective Equipment; and Cybersecurity, Privacy & Data Protection).
LATEST KEY DEVELOPMENTS
Competition & State Aid
- European Commission proposes Regulation establishing a framework of measures for strengthening Europe's semiconductor ecosystem (European Chips Act) and adopts accompanying Communication
- European Commission approves new and amended Member State measures to support the economy
Trade / Export Controls
- European Commission proposes Regulation establishing a framework of measures for strengthening Europe's semiconductor ecosystem (European Chips Act) Medicines and Medical Devices
- EMA evaluates booster dose of COVID-19 vaccine Comirnaty in adolescents
- EMA publishes further clinical data for two COVID-19 medicines
Cybersecurity, Privacy & Data Protection
- European Commission publishes proposal to modify and prolong application of EU Digital COVID-19 Certificate Regulation
- European Commission announces new EU Strategy on Standardisation in support of a resilient, green and digital EU single market
- European Parliament publishes infographic on Cybersecurity: main and emerging threats in 2021
Attachments: COVID19 KEY EU DEVELOPMENTS No. 76.pdf
Originally published February 2022
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.